A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114

por Araki, Hikari, Takenaka, Toru, Takahashi, Koichi, Yamashita, Fumiaki, Matsuoka, Kazuaki, Yoshisue, Kunihiro, Ieiri, Ichiro
Publicado 2021

TAS2940, a novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations

por Oguchi, Kei, Araki, Hikari, Tsuji, Shingo, Nakamura, Masayuki, Miura, Akihiro, Funabashi, Kaoru, Osada, Akiko, Tanaka, Sakiho, Suzuki, Takamasa, Kobayashi, Susumu S., Mizuarai, Shinji
Publicado 2022